An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors

An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors

Abstract Background An increased relative eosinophil count (REC) has potential as a predictive biomarker for a beneficial clinical response and outcome to cancer immunotherapies. Therefore, the present study investigated the impact of an increased posttreatment REC on the prognosis of non‐small cell...

Full description

Bibliographic Details
Main Authors: Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Thoracic Cancer
Subjects:
dynamic biomarker
immune checkpoint inhibitors
increased eosinophil count
non‐small cell lung cancer
predictive factor
Online Access:https://doi.org/10.1111/1759-7714.15191

Internet

https://doi.org/10.1111/1759-7714.15191

Similar Items